PROTEIN-KINASE-C INHIBITORS INDUCE APOPTOSIS IN HUMAN-MALIGNANT GLIOMA CELL-LINES

被引:194
|
作者
COULDWELL, WT
HINTON, DR
HE, SK
CHEN, TC
SEBAT, I
WEISS, MH
LAW, RE
机构
[1] UNIV SO CALIF,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT MED,DIV ENDOCRINOL DIABET & HYPERTENS,LOS ANGELES,CA 90033
关键词
PROTEIN KINASE C; APOPTOSIS; GLIOMA; STAUROSPORINE; TAMOXIFEN;
D O I
10.1016/0014-5793(94)00415-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous work has demonstrated the importance of the protein kinase C (PKC) system in regulating glioma growth, and has led to clinical trials utilizing PKC inhibitors as adjuncts in the therapy of patients harboring malignant gliomas. This study was performed to explore the possibility that inhibition of PKC in gliomas was triggering an apoptosis signal. Glioma cell lines were treated with PKC inhibitors staurosporine (10 nM), and tamoxifen (10 mu M). DNA from cells treated with each of these drugs exhibited a 'ladder' pattern of oligonucleosome-sized fragments characteristic of apoptosis, thus suggesting that in glioma cells, these drugs may be cytocidal in action.
引用
收藏
页码:43 / 46
页数:4
相关论文
共 50 条
  • [21] INHIBITORS OF PROTEIN-KINASES INDUCE DIFFERENTIATION IN HUMAN NEUROBLASTOMA CELL-LINES
    ROCCHI, P
    FERRERI, AM
    SIMONE, G
    MAGRINI, E
    CAVALLAZZI, L
    PAOLUCCI, G
    [J]. ANTICANCER RESEARCH, 1995, 15 (04) : 1381 - 1385
  • [22] A ROLE FOR PROTEIN-KINASE-C IN THE MULTIDRUG-RESISTANCE PHENOTYPE OF HUMAN CARCINOMA KB CELL-LINES
    DREW, L
    WARR, JR
    RUMSBY, MG
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (03) : S447 - S447
  • [23] ISOLATION OF 2 CELL-LINES FROM A HUMAN-MALIGNANT GLIOMA SPECIMEN DIFFERING IN SENSITIVITY TO RADIATION AND CHEMOTHERAPEUTIC DRUGS
    ALLALUNISTURNER, MJ
    BARRON, GM
    DAY, RS
    DOBLER, KD
    MIRZAYANS, R
    [J]. RADIATION RESEARCH, 1993, 134 (03) : 349 - 354
  • [24] INTERACTION OF 3 HUMAN-MALIGNANT CELL-LINES WITH CHICK HYPOBLAST IN CULTURE
    VANPETEGHEM, MC
    BELLAIRS, R
    MAREEL, MM
    [J]. VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1983, 43 (02) : 199 - 212
  • [25] DIFFERENTIAL EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR RECEPTORS IN HUMAN-MALIGNANT GLIOMA CELL-LINES
    NISTER, M
    CLAESSONWELSH, L
    ERIKSSON, A
    HELDIN, CH
    WESTERMARK, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (25) : 16755 - 16763
  • [26] STRUCTURAL AND NUMERICAL CHROMOSOME-ABNORMALITIES IN HUMAN-MALIGNANT MELANOMA CELL-LINES
    BERTRAND, S
    LEFTHERIOTIS, E
    DORE, JF
    [J]. COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 1982, 294 (11): : 459 - 462
  • [27] HETEROTRANSPLANTATION OF HUMAN-MALIGNANT MELANOMA CELL-LINES IN ATHYMIC NUDE-MICE
    KANZAKI, T
    HASHIMOTO, K
    BATH, DW
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1979, 62 (05) : 1151 - 1158
  • [28] INHIBITION OF PROTEIN-KINASE-C DEPENDENT CELL-PROLIFERATION OF HUMAN LUNG-CANCER CELL-LINES BY THE DIHYDROPYRIDINE DEXNIGULDIPINE
    SCHULLER, HM
    ORLOFF, M
    REZNIK, GK
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (06) : 354 - 358
  • [29] INVOLVEMENT OF CHROMOSOME-6 IN REARRANGEMENTS IN HUMAN-MALIGNANT MELANOMA CELL-LINES
    PATHAK, S
    DRWINGA, HL
    HSU, TC
    [J]. CYTOGENETICS AND CELL GENETICS, 1983, 36 (03): : 573 - 579
  • [30] ESTABLISHMENT AND CHARACTERIZATION OF 5 CELL-LINES DERIVED FROM HUMAN-MALIGNANT GLIOMAS
    RUTKA, JT
    GIBLIN, JR
    DOUGHERTY, DY
    LIU, HC
    MCCULLOCH, JR
    BELL, CW
    STERN, RS
    WILSON, CB
    ROSENBLUM, ML
    [J]. ACTA NEUROPATHOLOGICA, 1987, 75 (01) : 92 - 103